肾元颗粒对db/db糖尿病肾病小鼠血管钙化的改善作用及其机制

doi:10.13481/j.1671-587x.20200301

摘要/Abstract

摘要： 目的：通过高磷诱导db/db糖尿病肾病（DN）小鼠血管钙化，探讨肾元颗粒对db/db DN小鼠血管钙化的改善作用及其可能机制。方法：将20只SPF级db/db小鼠随机分为模型组和肾元颗粒组（n=10），同系背景野生型（WT）小鼠作为空白组（n=10）。给药12周后，取各组小鼠血清、肾脏和胸主动脉组织。ELISA法检测各组小鼠血清FGF23水平，HE和von Kossa法检测各组小鼠胸主动脉病理形态表现以及钙盐沉积情况，实时荧光定量PCR （Real-time PCR）法检测各组小鼠肾脏组织中KlothomRNA和胸主动脉组织中Pit-1、Runx2及SM22α mRNA表达水平，Western blotting法检测各组小鼠肾脏组织中Klotho蛋白和胸主动脉组织中Pit-1、Runx2及SM22α蛋白表达水平，免疫组织化学法检测各组小鼠胸主动脉组织中Pit-1蛋白表达水平，免疫荧光法检测各组小鼠胸主动脉组织中SM22α和Runx2蛋白表达水平。结果：与空白组比较，模型组小鼠血清FGF23水平明显升高（P<0.05），肾脏组织中Klotho mRNA和蛋白表达水平明显降低（P<0.01），胸主动脉组织中Pit-1和Runx2 mRNA及蛋白表达水平明显升高（P<0.01），SM22α mRNA和蛋白表达水平明显降低（P<0.01），胸主动脉组织中Pit-1和Runx2蛋白表达水平明显升高（P<0.01），SM22α蛋白表达水平明显降低（P<0.01）。与模型组比较，肾元颗粒组小鼠血清FGF23水平降低（P<0.05），肾脏组织中Klotho mRNA和蛋白表达水平明显升高（P<0.01），胸主动脉组织中Pit-1和Runx2 mRNA及蛋白表达水平明显降低（P<0.01），胸主动脉组织中SM22α mRNA和蛋白表达水平明显升高（P<0.01）。结论：肾元颗粒可通过上调小鼠肾脏组织中Klotho蛋白表达水平，减少Pit-1表达水平，抑制FGF23/Pit-1信号通路，调节血管平滑肌细胞（VSMC）的表型转化，达到血管保护作用。

关键词: Klotho, 糖尿病肾病, 血管平滑肌细胞, 肾元颗粒, 血管钙化

Abstract: Objective: To investigate the improvement effect of Shenyuan Granule on the vascular calcification in the db/db diabetic nephropathy (DN) mice induced by high phosphorus and its possible mechanism. Methods: Twenty SPF db/db mice were randomly divided into model group(n=10) and Shenyuan Granule group(n=10), and the wild type (WT) mice were chosen as blank group(n=10). After treated for 12 weeks, the serum, kidney tissue and thoracic aorta tissue of the mice in various groups were taken. The serum FGF23 levels of the mice in various groups were detected by ELISA method;HE and von kossa staining were used to detect the pathomorphology of the thoracic aorta and calcium deposition of the mice in various groups; Real-time PCR method was used to detect the expression levels of Klotho mRNA in kidney tissue and Pit-1, Runx2 and SM22α mRNA in thoracic aorta tissue of the mice in various groups; Western blotting method was used to detect the expression levels of Klotho protein in kidney tissue and Pit-1, Runx2 and SM22α proteins in thoracic aorta tissue of the mice in various groups; immunohistochemisty method was used to detect the expression levels of Pit-1 protein in thoracic aorta tissue of the mice in various groups,and immunofluorescence method was used to detect the expression levels of SM22α and Runx2 proteins in thoracic aorta tissue of the mice in various groups. Results: Compared with blank group, the serum FGF23 level of the mice in model group was significantly increased (P<0.05), the expression levels of Klotho mRNA and protein in kidney tissue were significantly decreased (P<0.01), the expression levels of Pit-1 and Runx2 mRNA and proteins in thoracic aorta tissue were increased (P<0.01), the expression levels of SM22α mRNA and protein in thoracic aorta tissue were decreased (P<0.01),the expression levels of Pit-1 and Runx2 proteins in thoracic aorta tissue were increased(P<0.01), and the expression level of SM22α protein in thoracic aorta tissue was decreased (P<0.01).Compared with model group, the serum FGF23 level of the mice in Shenyuan Granule group was decreased (P<0.05), the expression levels of Klotho mRNA and protein in kidney tissue were increased(P<0.01), the expression levels of Pit-1 and Runx2 mRNA and protein in thoracic aorta tissue were decreased (P<0.01), and the expression levels of SM22α mRNA and protein in thoracic aorta tissue were increased (P<0.01). Conclusion: Shenyuan Granule can up-regulate the expression level of Klotho protein in kidney tissue of the mice, reduce the expression level of Pit-1, inhibit the FGF23/Pit-1 signaling pathway, and regulate the phenotypic transformation of vasular smooth muscle cell(VSMC) to achieve its protective effect on the blood vessels.

Key words: Klotho, diabetic nephropathy, vascular smooth muscle cells, Shenyuan Granule, vascular calcification

中图分类号:

R587.1

王岚, 朱国双, 孙龙, 王小琴. 肾元颗粒对db/db糖尿病肾病小鼠血管钙化的改善作用及其机制[J]. 吉林大学学报(医学版), 2020, 46(03): 431-438.

WANG Lan, ZHU Guoshuang, SUN Long, WANG Xiaoqin. Improvement effect of Shenyuan Granule on vascular calcification in db/db diabetic nephropathy mice and its mechanism[J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 431-438.

参考文献

[1] SIKORA A G, GELBARD A, DAVIES M A, et al. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy[J]. Clin Cancer Res, 2010, 16(6):1834-1844.
[2] DE BOER I H, RUE T C, HALL Y N, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States[J]. JAMA, 2011, 305(24):2532-2539.
[3] MAZZONE T. Increased prevalence of significant coronary artery calcification in patients with diabetes[J]. Diabetes Care, 2001, 24(8):1508.
[4] QUARLES L D. Role of FGF23 in vitamin D and phosphate metabolism:implications in chronic kidney disease[J]. Exp Cell Res, 2012, 318(9):1040-1048.
[5] IBRAHIM S, RASHED LA. Serum fibroblast growth factor-23 levels in chronic haemodialysis patients[J]. Int Urol Nephrol, 2009, 41(1):163-169.
[6] 詹理睿, 王小琴, 邹新蓉, 等. 肾元颗粒影响糖尿病小鼠肾脏中miR-199b-5p与钙磷代谢的研究[J]. 中华中医药学刊, 2017, 35(11):2819-2823.
[7] 陈立, 王小琴. Klotho基因调控的FGF23/FGFR1信号通路对人肾小管上皮细胞羟化酶表达的影响及肾元颗粒的干预作用[J].中华中医药杂志, 2019, 34(10):4547-4552.
[8] 宋纯东, 张霞, 宋丹丹, 等. 益气养阴活血方对糖尿病肾病大鼠肾组织WT1影响的实验研究[J]. 中国中医基础医学杂志, 2016, 22(5):626-627.
[9] 黄继汉, 黄晓晖, 陈志扬, 等. 药理试验中动物间和动物与人体间的等效剂量换算[J]. 中国临床药理学与治疗学, 2004(9):1069-1072.
[10] 贺薇薇, 冯汉鸽, 汪琦, 等. 肾安颗粒中淫羊藿和黄芪半仿生提取工艺研究[J]. 医药导报, 2010, 29(8):1060-1062.
[11] 王小琴, 谭大琦, 金劲松. 肾安颗粒治疗慢性肾衰竭的临床研究[J]. 中国中西医结合肾病杂志, 2003, 4(7):393-395.
[12] 邵朝弟, 王小琴, 李勇, 等. 肾安片治疗慢性肾功能衰竭30例临床研究[J].中医杂志, 2003, 44(3):194-196.
[13] 邹新蓉, 王小琴, 王长江, 等. 肾安颗粒对肾性骨病模型大鼠骨组织骨保护素表达的影响[J]. 江苏中医药, 2014, 46(7):71-73.
[14] 邹新蓉, 王小琴, 王长江. Klotho基因在残余肾模型大鼠肾脏的表达及淫羊藿、黄芪、大黄复方的干预作用研究[J]. 华南国防医学杂志, 2015, 29(3):196-200.
[15] 邹新蓉, 王小琴, 王长江, 等. 肾安颗粒对肾性骨病模型大鼠骨组织BMP-7表达及骨代谢的影响[J]. 湖北中医杂志, 2013, 35(4):11-13.
[16] SHAO J S, SIERRA O L, COHEN R, et al. Vascular calcification and aortic fibrosis:a bifunctional role for osteopontin in diabetic arteriosclerosis[J]. Arterioscler Thromb Vasc Biol, 2011, 31(8):1821-1833.
[17] WERNER A, DEHMELT L, NALBANT P. Na⁺-dependent phosphate cotransporters:the NaPi protein families[J]. J Exp Biol, 1998, 201(Pt 23):3135-3142.
[18] TAKEDA E, TAKETANI Y, MORITA K, et al. Sodium-dependent phosphate co-transporters[J]. Int J Biochem Cell Biol, 1999, 31(3/4):377-381.
[19] WU Y, HAN X, WANG L, et al. Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK/Pit-1 pathway[J]. Ren Fail, 2016, 38(10):1-9.
[20] GOETZ R, NAKADA Y, HU M C, et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation[J]. Proc Natl Acad Sci U S A, 2010, 107(1):407-412.
[21] KURO O M. Klotho and endocrine fibroblast growth factors:markers of chronic kidney disease progression and cardiovascular complications[J]. Nephrol Dial Transplant, 2019, 34(1):15-21.
[22] LINDERGL K, OLAUSON H, AMIN R, et al. Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function[J]. PLoS One, 2013, 8(4):e60658.
[23] KAN S, ISHIZAKA N, MITANI H, et al. Iron chelation and a free radical scavenger suppress angiotensin Ⅱ-induced downregulation of klotho, an anti-aging gene, in rat[J]. FEBS Lett, 2003, 551(1):58-62.
[24] HU M C, SHI M, ZHANG J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease[J]. J Am Soc Nephrol, 2011, 22(1):124-136.
[25] SMITH E R, HOLT S G, HEWITSON T D. FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-beta autoinduction[J]. Int J Biochem Cell Biol, 2017, 92:63-78.
[26] YAMAZAKI M, OZONO K, OKADA T, et al. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells[J]. J Cell Biochem, 2010, 111(5):1210-1221.
[27] ZHANG L, XIE P, WANG J, et al. Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension[J]. J Biol Chem, 2010, 285(18):13666-13677.
[28] ABDEL-RAHMAN E M, OKUSA M D. Effects of aging on renal function and regenerative capacity[J]. Nephron Clin Pract, 2014, 127(1-4):15-20.